150 related articles for article (PubMed ID: 17534448)
21. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
22. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
Ruiz-Ruiz MC; López-Rivas A
Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapeutic treatment is associated with Notch1 induction in cutaneous T-cell lymphoma.
Kamstrup MR; Biskup E; Manfè V; Savorani C; Liszewski W; Wirèn J; Specht L; Gniadecki R
Leuk Lymphoma; 2017 Jan; 58(1):171-178. PubMed ID: 27181628
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
[TBL] [Abstract][Full Text] [Related]
25. Genotoxic polycyclic aromatic hydrocarbons fail to induce the p53-dependent DNA damage response, apoptosis or cell-cycle arrest in human prostate carcinoma LNCaP cells.
Hrubá E; Trilecová L; Marvanová S; Krcmár P; Vykopalová L; Milcová A; Líbalová H; Topinka J; Starsíchová A; Soucek K; Vondrácek J; Machala M
Toxicol Lett; 2010 Sep; 197(3):227-35. PubMed ID: 20542099
[TBL] [Abstract][Full Text] [Related]
26. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
Mungamuri SK; Yang X; Thor AD; Somasundaram K
Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424
[TBL] [Abstract][Full Text] [Related]
27. Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
Hsu KW; Fang WL; Huang KH; Huang TT; Lee HC; Hsieh RH; Chi CW; Yeh TS
Oncotarget; 2016 Jun; 7(25):38036-38051. PubMed ID: 27191259
[TBL] [Abstract][Full Text] [Related]
28. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression.
Cantrell MA; Ebelt ND; Pfefferle AD; Perou CM; Van Den Berg CL
Oncotarget; 2015 May; 6(14):11863-81. PubMed ID: 25970777
[TBL] [Abstract][Full Text] [Related]
29. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
30. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
31. 5-Lipoxygenase is a direct p53 target gene in humans.
Gilbert B; Ahmad K; Roos J; Lehmann C; Chiba T; Ulrich-Rückert S; Smeenk L; van Heeringen S; Maier TJ; Groner B; Steinhilber D
Biochim Biophys Acta; 2015 Aug; 1849(8):1003-16. PubMed ID: 26070487
[TBL] [Abstract][Full Text] [Related]
32. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
33. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
34. Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells.
Duan L; Yao J; Wu X; Fan M
Biol Cell; 2006 Aug; 98(8):479-90. PubMed ID: 16608439
[TBL] [Abstract][Full Text] [Related]
35. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
37. p53 regulates thymic Notch1 activation.
Laws AM; Osborne BA
Eur J Immunol; 2004 Mar; 34(3):726-734. PubMed ID: 14991602
[TBL] [Abstract][Full Text] [Related]
38. COX-2 regulates Snail expression in gastric cancer via the Notch1 signaling pathway.
Ye Y; Liu M; Yuan H; Ning S; Wang Y; Chen Z; Ji R; Guo Q; Li Q; Zhou Y
Int J Mol Med; 2017 Aug; 40(2):512-522. PubMed ID: 28586004
[TBL] [Abstract][Full Text] [Related]
39. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
Sung HY; Wu HG; Ahn JH; Park WY
Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy.
Kim B; Stephen SL; Hanby AM; Horgan K; Perry SL; Richardson J; Roundhill EA; Valleley EM; Verghese ET; Williams BJ; Thorne JL; Hughes TA
BMC Cancer; 2015 Sep; 15():634. PubMed ID: 26362310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
